Application of arterial spin labeling perfusion MRI to differentiate benign from malignant intracranial meningiomas

Xin J Qiao1, Hyun Grace Kim1, Danny J J Wang2

  • 1Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Abstract

Insights

Arterial spin labeling (ASL) MRI can differentiate meningioma grades. Homogeneous hyper-perfusion indicates benign (WHO Grade I) tumors, while heterogeneous or absent hyper-perfusion suggests higher grades (WHO II-III).

Area of Science:

  • Neuroradiology
  • Medical Imaging
  • Oncology

Background:

  • Meningiomas are common primary brain tumors.
  • Accurate grading of meningiomas (WHO Grade I-III) is crucial for treatment planning.
  • Non-invasive methods to distinguish meningioma grades are needed.

Purpose of the Study:

  • To evaluate the potential of Magnetic Resonance (MR) arterial spin labeling (ASL) for differentiating meningioma grades.
  • To correlate ASL-derived perfusion patterns with histopathological tumor grading.

Main Methods:

  • Pseudo-continuous ASL with 3D background suppressed gradient and spin echo (GRASE) was performed on 54 meningioma patients.
  • Cerebral Blood Flow (CBF) color maps were visually assessed for perfusion patterns.
  • Patterns were correlated with WHO histopathological grades.

Main Results:

  • Three distinct perfusion patterns were identified: homogeneous hyper-perfusion (Pattern 1), heterogeneous hyper-perfusion (Pattern 2), and no substantial hyper-perfusion (Pattern 3).
  • Pattern 1 strongly correlated with WHO Grade I meningiomas (P<0.0001).
  • Patterns 2 and 3 were predictive of higher-grade (WHO II-III) meningiomas with high odds ratios (OR=49.6 univariate, OR=186.4 multivariate).

Conclusions:

  • Qualitative assessment of ASL CBF maps can effectively distinguish between benign (WHO Grade I) and higher-grade (WHO Grade II-III) intracranial meningiomas.
  • ASL imaging may aid in non-invasively determining tumor grade, potentially influencing therapeutic strategies.